Gelesis Holdings, Inc.
Gelesis Holdings, Inc. (GLS) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001805087 · GLS · NYSE · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001805087 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Gelesis Holdings, Inc. (NYSE: GLS) has submitted 251 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2022. As a Healthcare sector company with CIK 0001805087, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Gelesis Holdings, Inc.'s most comprehensive regulatory disclosure. The most recent Gelesis Holdings, Inc. 10-K was filed on 2023-03-28 for fiscal year ending 2023. Historical GLS 10-K annual reports are available from 2020 through 2023.
Investors researching Gelesis Holdings, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
GLS SEC Filings · 8 questionsGelesis Holdings, Inc. (GLS) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 251 filings and access original documents at no cost. Gelesis Holdings, Inc.'s CIK is 0001805087.